SCHEMBL7878082

SCHEMBL7878082

CN(C(=N)N)C(=O)c1cc2cccc(Oc3ccccc3)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.39
F10 P00742 4/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CTNNB1 P35222 1/20 0.38
FLT3 P36888 2/20 0.38
TSPO P30536 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
F2 P00734 3/20 0.37
PLG P00747 2/20 0.37
PLAU P00749 2/20 0.37
PLAT P00750 2/20 0.37
RHEB Q15382 1/20 0.37
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
NSD2 O96028 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7884333 0.91 HRH4 (0.36) BRD4F10MEN1USP2ALDH1A1
Hydrochloric Acid SCHEMBL7880727 0.90 HRH4 (0.36) BRD4F10MEN1USP2ALDH1A1
SCHEMBL7881903 0.90 F10 (0.37) BRD4F10FLT3HRH4F2
SCHEMBL7881241 0.90 IDO1 (0.40) F10HSD17B10FLT3HRH4F2
SCHEMBL7873962 0.89 ST14 (0.38) F10MEN1KMT2AFLT3HRH4
SCHEMBL7873374 0.88 HDAC3 (0.39) BRD4MEN1USP2ALDH1A1HPGD
SCHEMBL7879419 0.87 IDO1 (0.47) F10ALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL7882045 0.87 F10 (0.41) F10MEN1KMT2AFLT3HRH4
SCHEMBL7880200 0.87 RXFP1 (0.38) MEN1KMT2AFLT3HRH4TP53
Hydrochloric Acid SCHEMBL7878079 0.87 HDAC3 (0.38) BRD4MEN1USP2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed